NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

SAN DIEGO - MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company, announced that it is continuing to evaluate strategic alternatives to maximize shareholder value, including ...

The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently concluded its 2024 Special Meeting of Stockholders with significant ...

An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.

The pharma industry has invested greatly in IT systems and optimized data and content management. Medical device companies can learn from pharma's experience — and it will ease the regulatory burden.

The Indian pharmaceutical industry is concerned over the talent gap the sector is facing, particularly in areas like data science, digital marketing, and innovative R&D. The industry is undergoing ...

Meanwhile, MEI Pharma has enlisted Oppenheimer for a strategic review to optimize shareholder value. This comes after the pharmaceutical company announced significant leadership changes and strategic ...